Jiangsu Hengrui Pharmaceuticals dividend and valuation

600276 · SSE · CNY

Compare Jiangsu Hengrui Pharmaceuticals
¥47.00Change from previous close: +0.26%Absolute change: +¥0.12

Close · November 20, 2026

Valuation

Jiangsu Hengrui Pharmaceuticals paid ¥0.20 per share in dividends over the last 12 months (yield 0.4%). Last ex-dividend date: May 27, 2026. The P/E ratio is 35.1. The average price target of 18 analysts is ¥71.64.

Data as of November 22, 2026

Jiangsu Hengrui Pharmaceuticals compared with similar companies

Jiangsu Hengrui Pharmaceuticals's P/E (trailing 12 months): 35.1, −15% against the median of a group of 11 similar companies (41.2).

Jiangsu Hengrui Pharmaceuticals's metrics compared with similar companies
MetricJiangsu Hengrui PharmaceuticalsMedian25th–75th percentileBand
P/E (trailing 12 months)35.141.226.8 – 83.7Middle
Forward P/E30.930.923.6 – 50.6Middle
EV/EBITDA27.524.617.9 – 39.4Middle
Price/book4.644.643.35 – 11.9Middle
Price/sales9.509.504.06 – 14.2Middle
Gross margin86.4%75.9%64.1% – 84.0%High
Operating margin27.4%24.1%19.7% – 32.8%Middle
Net margin27.0%17.8%13.0% – 32.2%Middle
ROE13.9%15.2%13.5% – 19.8%Middle
Debt/equity0.000.110.02 – 0.44Low

Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.

TickerLandia analysisHow it is calculated

Companies in the group: same industry, similar size

Jiangsu Hengrui Pharmaceuticals: valuation over time

On the latest fiscal year's earnings (2025), Jiangsu Hengrui Pharmaceuticals's P/E today is 39.8, below the median of its last 10 fiscal years (62.1; between 41.3 and 93.8 from 2016 to 2025). Relative to earnings, the stock costs less than it used to. The dividend yield (0.4%) is above the median of the last 10 fiscal years (0.3%).

Jiangsu Hengrui Pharmaceuticals P/E and dividend yield at each fiscal year end
Fiscal yearPrice at year endEarnings per shareP/EDividend per shareYield
2025¥59.57¥1.1850.5¥0.200.3%
2024¥45.90¥1.0045.9¥0.200.4%
2023¥45.23¥0.6866.5¥0.200.4%
2022¥38.53¥0.6163.2¥0.160.4%
2021¥50.71¥0.7171.4¥0.160.3%
2020¥92.88¥0.9993.8¥0.170.2%
2019¥60.78¥0.8372.9¥0.160.3%
2018¥30.53¥0.6447.8¥0.130.4%
2017¥30.71¥0.5061.0¥0.060.2%
2016¥16.88¥0.4141.3¥0.050.3%

TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.

TickerLandia analysisHow it is calculated

Other metrics

Valuation multiples

Market cap
¥311.95B
Enterprise value
¥271.65B
PEG
0.93
EV/revenue
8.27

Profitability and growth

ROA
7.8%
Revenue growth (year over year)
-14.5%
Earnings growth (year over year)
-14.6%

Financial health

Total cash
¥38.84B
Total debt
¥67.98M
Current ratio
7.91
Quick ratio
7.25

Dividends

Annual dividend per share
¥0.20
Dividend yield
0.4%
Payout ratio
14.9%
Ex-dividend date
May 27, 2026

Analysts and estimates

Average price target
¥71.64
Median price target
¥70.55
High price target
¥111.00
Low price target
¥50.00
Analysts with a price target
18
Consensus
Strong buy
Forward EPS
¥1.52
EPS estimate, current year
¥1.39

Shares and trading

Beta
0.04
Average volume
60.76M
Shares outstanding
6.38B
Float
3.73B
Institutional ownership
11.2%
Insider ownership
46.4%